BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22658439)

  • 1. Estimation of the optimal brachytherapy utilization rate in the treatment of gynecological cancers and comparison with patterns of care.
    Thompson SR; Delaney GP; Gabriel GS; Jacob S; Das P; Barton MB
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):400-5. PubMed ID: 22658439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the optimal brachytherapy utilisation rate in the treatment of vaginal cancer and comparison with patterns of care.
    Thompson SR; Delaney GP; Gabriel GS; Jacob S; Barton MB
    J Med Imaging Radiat Oncol; 2012 Aug; 56(4):483-9. PubMed ID: 22883660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the optimal brachytherapy utilization rate in the treatment of carcinoma of the uterine cervix: review of clinical practice guidelines and primary evidence.
    Thompson S; Delaney G; Gabriel GS; Jacob S; Das P; Barton M
    Cancer; 2006 Dec; 107(12):2932-41. PubMed ID: 17109449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of optimal brachytherapy utilization rate in the treatment of malignancies of the uterine corpus by a review of clinical practice guidelines and the primary evidence.
    Thompson SR; Delaney G; Gabriel GS; Jacob S; Das P; Barton M
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):849-58. PubMed ID: 18448273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The epidemiology of cancers of the female genital organs].
    Kato I; Tominaga S; Kuroishi T
    Gan No Rinsho; 1989 Jan; 35(1):1-8. PubMed ID: 2646463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of care study of brachytherapy in New South Wales: malignancies of the uterine corpus.
    Thompson SR; Delaney GP; Gabriel GS; Barton MB
    J Contemp Brachytherapy; 2015 Jun; 7(3):224-30. PubMed ID: 26207111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-dose gynecologic endocavitary brachytherapy. Technical and dosimetric aspects].
    Grillo Ruggieri F; Parietti E; Bistolfi F; Tomassini E; Papadia S; Leonardi S; Siragusa A; Guglielmi M; Brizzi C; Scielzo G
    Radiol Med; 1989 Oct; 78(4):373-9. PubMed ID: 2595028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the development of gynecological radiotherapy; 50 years of experiences in the 1st Women's Hospital of Munich University].
    Ries J
    Munch Med Wochenschr; 1967 Jan; 109(1):3-9. PubMed ID: 5340254
    [No Abstract]   [Full Text] [Related]  

  • 9. [Association of radiotherapy and chemotherapy: targeted therapies in gynecological cancers].
    Barillot I; Haie-Meder C
    Bull Cancer; 2009 Mar; 96(3):271-83. PubMed ID: 19318305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I--malignancies of the cervix, ovary, vagina and vulva.
    Delaney G; Jacob S; Barton M
    Cancer; 2004 Aug; 101(4):671-81. PubMed ID: 15305396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of brachytherapy resources in Latin America: a patterns-of-care survey.
    Guedea F; Ventura M; Londres B; Pinillos L; Poitevin A; Ospino R; Cordova A; Camacho R; Britton R; Sarria G; Sempere P; Delgado RL; Bulnes R; Ventura NC; Limbergen EV; Haie-Meder C; Kovacs G
    Brachytherapy; 2011; 10(5):363-8. PubMed ID: 21296032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of the gynecological and mammary cancer to the HOMEL and in the CUGO Cotonou, BĂ©nin].
    Tonato Bagnan JA; Denakpo JL; Aguida B; Hounkpatin L; Lokossou A; De Souza J; Perrin RX
    Bull Cancer; 2013 Feb; 100(2):141-6. PubMed ID: 23449498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy for gynecologic malignancies.
    Bradley KA; Petereit DG
    Hematol Oncol Clin North Am; 2006 Apr; 20(2):347-61. PubMed ID: 16730298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiotherapy of gynecologic cancers].
    Veraguth P; Alessandrini G; Berthier G; Merz WR
    Rev Med Suisse Romande; 1969 May; 89(5):429-47. PubMed ID: 5385887
    [No Abstract]   [Full Text] [Related]  

  • 15. [Occurrence of carcinoma of the vulva and vagina following irradiation of cervix carcinoma].
    Tsukiyama I; Kakehi M; Ono R; Watai K; Yanagawa S; Kasamatsu T
    Gan No Rinsho; 1984 Aug; 30(10):1285-9. PubMed ID: 6481964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
    Shen X; Keith SW; Mishra MV; Dicker AP; Showalter TN
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1154-9. PubMed ID: 22270175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines.
    Thompson SR; Delaney GP; Jacob S; Shafiq J; Wong K; Hanna TP; Gabriel GS; Barton MB
    Radiother Oncol; 2016 Jan; 118(1):118-21. PubMed ID: 26776443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the diagnosis of female genital carcinomas in the gynecological outpatient clinic].
    Wagenitz H
    Z Arztl Fortbild (Jena); 1967 May; 61(10):521-7. PubMed ID: 5599087
    [No Abstract]   [Full Text] [Related]  

  • 19. [The influence of radium therapie on the yeast contamination of the vagina (author's transl)].
    Mendling W; Schnell JD; Spiecker R
    Geburtshilfe Frauenheilkd; 1979 Dec; 39(12):1017-20. PubMed ID: 391638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of care study of brachytherapy in New South Wales: cervical cancer treatment quality depends on caseload.
    Thompson SR; Delaney GP; Gabriel GS; Barton MB
    J Contemp Brachytherapy; 2014 Mar; 6(1):28-32. PubMed ID: 24790619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.